Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$557K Sell
3,495
-9,663
-73% -$1.62M ﹤0.01% 4151
2014
Q2
$2.29M Buy
13,158
+2,158
+20% +$322K ﹤0.01% 2746
2014
Q1
$1.59M Sell
11,000
-31,868
-74% -$4.68M ﹤0.01% 3011
2013
Q4
$4.61M Buy
42,868
+26,934
+169% +$2.47M ﹤0.01% 1941
2013
Q3
$1.25M Sell
15,934
-6,888
-30% -$527K ﹤0.01% 3089
2013
Q2
$1.66M Buy
+22,822
New +$1.46M ﹤0.01% 2751

Other funds holding ILMN

UBS's ILMN Position: Q3 2014 in Review

UBS reduced its Illumina (ILMN) stake by 12% in Q3 2014, selling an estimated $3.47M and leaving 158,675 shares worth $25.3M. The position accounts for 0.02% of the portfolio, ranked #808.

UBS first reported a position in ILMN in Q2 2013 and has held it in 6 quarters since. The position peaked at $31.2M in Q2 2014. 480 funds tracked by Wall St. Rank hold ILMN as of Q3 2014.

  • UBS held 158,675 shares of Illumina worth $25.3M as of Q3 2014.
  • UBS sold 20,742 Illumina shares in Q3 2014, an estimated $3.47M.
  • Illumina made up 0.02% of UBS's portfolio in Q3 2014, its #808 holding.
  • UBS first reported a position in Illumina in Q2 2013 and has held it in 6 quarters since.
  • UBS's Illumina position peaked at $31.2M in Q2 2014.
  • 480 funds tracked by Wall St. Rank held Illumina as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.